U.S. State Life Tables, 2019

Arias, Elizabeth; Xu, Jiaquan; Tejada-Vera, Betzaida; Bastian, Brigham

doi:10.15620/cdc:113251

Cited by 66 publications

(73 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The probability of the PFD state transition to the death state was assumed to be natural mortality. 14 , 15 The relative 5-year survival rate of patients diagnosed with MPM was 10% or less. Thus, the time horizon of the model was set to 10 years.…”

Section: Methodsmentioning

confidence: 99%

Cost-effectiveness analysis of nivolumab plus ipilimumab versus chemotherapy as the first-line treatment for unresectable malignant pleural mesothelioma

Liu

Cao

et al. 2022

Ther Adv Med Oncol

View full text Add to dashboard Cite

Introduction: This study evaluated the cost-effectiveness of nivolumab plus ipilimumab (NI) versus pemetrexed plus cisplatin/carboplatin (C) as the first-line treatment for unresectable malignant pleural mesothelioma (MPM) from the perspective of US payers. Methods: A 10-year partitioned survival model was constructed using survival and safety data from the CheckMate 743 clinical trial. The output metrics of the model included the patient’s lifetime quality-adjusted life years (QALYs), lifetime costs, and incremental cost-effectiveness ratio (ICER). Only direct medical costs were considered. One-way and probabilistic sensitivity analyses were conducted to assess the robustness of the results. Results: Among all randomized patients, group NI had an ICER of $475,677/QALY relative to group C. Among patients with epithelioid histology, group NI had an ICER of $760,955/QALY. Among patients with non-epithelioid histology, group NI had an ICER of $418,348/QALY. The ICERs of all three populations exceeded the willingness-to-pay threshold ($150,000). The results of one-way sensitivity analysis revealed that the cost of nivolumab had a great influence on the results. The results of probabilistic sensitivity analysis demonstrated that the possibility of NI being more economical in all randomized patients and in patients with non-epidemiology histology was 0. In patients with epithelioid histology, the probability that NI had an economic advantage was 0.6%. Conclusions: From the perspective of US payers, in patients with unresectable MPM, NI has no economic advantage over C.

show abstract

Section: Methodsmentioning

confidence: 99%

Cost-effectiveness analysis of nivolumab plus ipilimumab versus chemotherapy as the first-line treatment for unresectable malignant pleural mesothelioma

Liu

Cao

et al. 2022

Ther Adv Med Oncol

View full text Add to dashboard Cite

show abstract

“…We use the adjusted death counts to estimate age-specific mortality rates (nMx) for both years and, subsequently, estimate the remaining life table columns using standard life table relationships (Preston, Heuveline, and Guillot 2000). For comparison, we present published life expectancy values for 2019 (Arias and Xu 2022) and provisional estimates for 2020 (Arias et al 2021a) for the total US population and the Latino, White, and Black populations by sex.…”

Section: Methodsmentioning

confidence: 99%

Life expectancy loss among Native Americans during the COVID-19 pandemic

Goldman¹,

Andrasfay²

2022

DemRes

View full text Add to dashboard Cite

BACKGROUNDThere has been little systematic research on the mortality impact of COVID-19 in the Native American population. OBJECTIVEWe provide estimates of loss of life expectancy in 2020 and 2021 relative to 2019 for the Native American population. METHODSWe use data on age-specific all-cause mortality rates from CDC WONDER and the 2019 life table recently released by the National Vital Statistics System for Native Americans to calculate life tables for the Native American population in 2020 and 2021 and to obtain estimates of life expectancy reductions during the COVID-19 pandemic. RESULTSThe pandemic has set Native Americans further behind other major racial/ethnic groups in terms of life expectancy. The estimated loss in life expectancy at birth for Native Americans is 4.5 years in 2020 and 6.4 years in 2021 relative to 2019. CONCLUSIONSThese results underscore the disproportionate share of deaths experienced by Native Americans: a loss in life expectancy at birth in 2020 that is more than three years above that for Whites and about 1.5 years above the losses for the Black and Latino populations. Despite a successful vaccination campaign among Native Americans, the estimated loss in life expectancy at birth in 2021 unexpectedly exceeds that in 2020.

show abstract

“…NCHC with LIOHFM), the most commonly co-occurring profiles were ELIFH with FIOA (6 CBGs). Since households can belong to multiple profiles, this may suggest that areas of spatial overlap have high concentrations of older ELIFH households, a likely consequence of the 5-year gap between men's (76.1 years) and women's (81.6 years) life expectancy in Arizona (Arias et al, 2022). Colocation of all profiles is more likely within the two main MH clusters (Flowing Wells and Southern Tucson), near or spanning the border between the City of Tucson and Unincorporated Pima County.…”

Section: Geographies Of Mh Vulnerability: How Do the Geographies Of M...mentioning

confidence: 99%

The Manufactured Housing Mosaic: A novel approach to differentiating and measuring social vulnerability

Kear¹,

McCann

Hibberd³

et al. 2022

Preprint

View full text Add to dashboard Cite

Efforts to measure and map spatial variation in vulnerability have long employed manufactured and mobile homes (MH) as an indicator of vulnerability. This practice reinforces perceptions of MH as a inferior form of home. We present a novel approach to measuring social vulnerability among MH residents that seeks to internally differentiate the MH population and produce deeper insights into the complex relationship between housing type, social vulnerability, and housing insecurity. We apply logistic principal component analysis (LPCA) to census microdata from 1,094 MH households in Pima County, Arizona to identify components with variable loadings consistent with social vulnerability and housing security interpretations. Four vulnerability profiles emerge from this analysis. Profiles were corroborated using interview data from 72 MH households. The article provides new insights into within-housing-type variation in the relationship between vulnerability and housing insecurity, and (ii) the role of housing type in mediating that relationship.

show abstract

U.S. State Life Tables, 2019

Abstract: This report presents complete period life tables for each of the 50 states and District of Columbia by sex, based on 2019 age-specific death rates.

Cited by 66 publications

References 0 publications

Cost-effectiveness analysis of nivolumab plus ipilimumab versus chemotherapy as the first-line treatment for unresectable malignant pleural mesothelioma

Cost-effectiveness analysis of nivolumab plus ipilimumab versus chemotherapy as the first-line treatment for unresectable malignant pleural mesothelioma

Life expectancy loss among Native Americans during the COVID-19 pandemic

The Manufactured Housing Mosaic: A novel approach to differentiating and measuring social vulnerability

Contact Info

Product

Resources

About